Concerns about PFAS contamination did not suddenly emerge in recent years. In fact, evidence of potential health risks dates back several decades.
As early as the 1960s and 1970s, major chemical companies such as DuPont and 3M had already conducted internal toxicology studies on PFOA, one of the most widely used PFAS chemicals. These studies identified troubling health effects, including potential birth defects and other toxic impacts. However, most of these findings were not disclosed to the public, and only limited information was shared with the U.S. Environmental Protection Agency (EPA). Some significant negative results were reportedly withheld entirely.
Although such nondisclosure arguably violated the Toxic Substances Control Act (TSCA), the law’s structure made regulatory intervention difficult. TSCA relied heavily on passive oversight and granted strong protections for corporate trade secrets, leaving the EPA with limited ability to investigate or require disclosure.
Public awareness of PFAS risks began to change in 1999, when the Tennant family filed a lawsuit against DuPont over contamination of their farmland in West Virginia. During the litigation process, thousands of previously confidential internal company documents were released. These documents revealed that DuPont had long known about the potential dangers of PFOA. The case became a turning point, bringing PFAS pollution into the public spotlight and prompting greater regulatory attention.
In response to mounting scrutiny, the EPA launched the PFOA Stewardship Program in the mid-2000s. Under this initiative, eight major chemical companies voluntarily agreed to phase out PFOA and related chemicals by 2015. While the program was widely viewed as a regulatory success, it relied primarily on voluntary industry commitments rather than binding federal regulations. This reflected the EPA’s continued reliance on cooperative and passive regulatory approaches.
However, the phase-out of certain PFAS chemicals did not solve the broader contamination problem. Many legacy PFAS remain in the environment due to their extreme persistence and resistance to degradation. At the same time, manufacturers began shifting to alternative PFAS compounds whose long-term health and environmental effects remain poorly understood.
This pattern is often described as “regrettable substitution,” in which hazardous chemicals are replaced by structurally similar alternatives that may pose similar risks. Regulatory oversight has struggled to keep pace with these changes. The EPA has historically been slow to identify the hazards of newly introduced chemicals, and regulatory review is often complicated by Confidential Business Information (CBI) protections that limit transparency and delay risk assessment.
As scientific evidence continued to grow, PFAS began attracting increasing attention from researchers and public health institutions. One notable example was the C8 Health Project, a large-scale epidemiological study conducted in the 2000s. The study linked PFAS exposure to several human diseases, including kidney and testicular cancers, thyroid disease, and immune system effects.
Despite the expanding body of scientific evidence, federal regulatory action remained limited for many years. From the mid-2000s to the mid-2010s, the EPA largely focused on conducting toxicological research and issuing non-enforceable health advisories, rather than implementing binding regulations.
It was not until 2019 that the EPA released its first comprehensive PFAS Action Plan, marking the beginning of more coordinated federal regulatory efforts. Notably, this initiative came nearly fifty years after federal agencies first became aware of PFAS substances, highlighting the long gap between early industry knowledge and meaningful regulatory action.
Understanding the early history of PFAS regulation helps explain why PFAS contamination remains such a persistent environmental challenge today. Decades of limited transparency, slow regulatory response, and reliance on voluntary industry action allowed these chemicals to spread widely before effective controls were implemented.
（Frank Wang)